We also identified TTR macrophages in an independent dataset from the Tumor Profiler consortium where TTR macrophages were detected predominantly in melanoma patients resistant to targeted therapy but much less in patients treated with other therapies, suggesting that these macrophages are specific for TTR. This evidence concerns the gene TTR and melanoma.